In a Proactive StockTube interview, Nicolas Serandour, chief operating officer (COO) and chief finance officer (CFO) Advanced Oncotherapy (AVO), says the firm is looking at “disrupting the market” with its proton cancer treatment technology.
Home » Advanced Oncotherapy (AVO) » Advanced Oncotherapy (AVO) looking at “disrupting” the cancer treatment market
Advanced Oncotherapy (AVO) looking at “disrupting” the cancer treatment market
